While the first coronavirus vaccine has received emergency use authorization from the FDA, the author of today’s article points out that “The coronavirus vaccine race… Read More »The Best Bets Right Now In The Ongoing COVID Vaccine Race For Aggressive – And Cautious – Investors
The Shelton Green Alpha Fund is up more than 100% year-to-date and is among the best-performing funds of 2020 – and a big reason for… Read More »The Co-Managers Of An Outperforming Fund Share 3 Biotech Firms Poised To Solve Future Disease Outbreaks
Like the Pfizer and Moderna vaccines, the COVID-19 vaccine candidate being developed by the mid-cap biotech featured in today’s article uses a messenger RNA (mRNA)… Read More »Is This One-Dose mRNA COVID Vaccine Stock A Must-Buy?
In addition to highlighting three new biotech companies to watch – all of which are life sciences companies and include recent Nasdaq IPOs – today’s… Read More »New Stocks To Watch In Biotech, Cannabis, Cybersecurity & More!
“The best biotech companies offer a nice balance between several established drugs bringing the company consistent income along with a robust pipeline of potential blockbuster… Read More »Significant Upside Potential (And Dividends) Make These 3 Biotech Stocks To Watch
Regarding penny stocks, the author of today’s article notes that “These have become some of the hottest topics in the stock market today. Whether it’s… Read More »Penny Stocks To Watch: 4 Under $2.50
With two innovative cancer treatment candidates that seek to block the “cloaking signal” used by cancer cells to trick the immune system into not attacking… Read More »Blocking Cancer’s “Cloaking Signal” Creates A Massive Opportunity For This Biotech
When it comes to biotech in 2021, the author of today’s article expects the sector to remain very attractive, noting that “Valuations are quite reasonable… Read More »3 Stocks To Play Biotech’s Continued Outperformance In 2021
“If tech has been a rocket, small-caps have been a submarine,” analogize analysts at Jefferies, noting that “With the exception of the post-corporate tax reform… Read More »Is The Small-Cap “Submarine” Preparing To Rise?
“We all love to buy pharma stocks when they release positive clinical data, but they can also be solid choices for investors looking for businesses… Read More »2 Pharma Stocks To Consider Picking Up On The Dip